We are live on ! Find out more
ENTX icon

Entera Bio
ENTX

12 hedge funds and large institutions have $14.2M invested in Entera Bio in 2022 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 0 increasing their positions, 4 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 12 → 12 (0)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

0% more first-time investments, than exits

New positions opened: 4 | Existing positions closed: 4

2.47% less ownership

Funds ownership: 19.65% → 17.19% (-2.5%)

11% less capital invested

Capital invested by funds: $15.9M → $14.2M (-$1.72M)

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 4

Holders
12
Holders Change
–
Holders Change %
0%
% of All Funds
0.19%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
4
Increased
–
Reduced
4
Closed
4
Calls
$550K
Puts
–
Net Calls
+$550K
Net Calls Change
-$36K

Top Buyers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
+$111K
2
PNC Financial Services Group
PNC Financial Services Group
Pennsylvania
+$24K
3
UBS Group
UBS Group
Switzerland
+$11.2K
4
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
+$1.39K

Top Sellers

Rank Fund Capital Flow
1
AIM
ARK Investment Management
Florida
-$1.65M
2
Renaissance Technologies
Renaissance Technologies
New York
-$113K
3
Bank of America
Bank of America
North Carolina
-$39K
4
Citadel Advisors
Citadel Advisors
Florida
-$30.1K
5
SFI
Susquehanna Fundamental Investments
Pennsylvania
-$29K
Name Holding Trade Value Shares
Change 		Change in
Stake
KCM
1
Knoll Capital Management
Florida
$7.13M – – –
RCM
2
RA Capital Management
Massachusetts
$6.75M – – –
Millennium Management
3
Millennium Management
New York
$132K +$111K +46,209 New
Geode Capital Management
4
Geode Capital Management
Massachusetts
$50K – – –
Citadel Advisors
5
Citadel Advisors
Florida
$43K -$30.1K -12,531 -45%
AWM
6
Altium Wealth Management
New York
$34K – – –
PNC Financial Services Group
7
PNC Financial Services Group
Pennsylvania
$29K +$24K +10,000 New
Morgan Stanley
8
Morgan Stanley
New York
$14K -$2.43K -1,012 -17%
UBS Group
9
UBS Group
Switzerland
$13K +$11.2K +4,660 New
AIM
10
ARK Investment Management
Florida
$5K -$1.65M -689,178 -100%
Royal Bank of Canada
11
Royal Bank of Canada
Ontario, Canada
$2K +$1.39K +581 New
Renaissance Technologies
12
Renaissance Technologies
New York
– -$113K -40,100 Closed
Bank of America
13
Bank of America
North Carolina
– -$39K -13,866 Closed
SFI
14
Susquehanna Fundamental Investments
Pennsylvania
– -$29K -10,200 Closed
Simplex Trading
15
Simplex Trading
Illinois
– -$1.64K -682 -75%

ENTX Hedge Fund Activity: Q1 2022 in Review

12 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in Entera Bio (ENTX) for Q1 2022, worth a combined $14.2M — down 11% from $15.9M a quarter earlier.

Fund positioning in ENTX was balanced in Q1 2022: 4 funds opened new positions, 4 closed out, 0 added to existing stakes and 4 trimmed.

The largest buyer was Millennium Management, opening a new position worth an estimated $111K. The largest seller was ARK Investment Management, cutting an estimated $1.65M.

  • 12 institutional investors held Entera Bio (ENTX) as of Q1 2022, unchanged from Q4 2021.
  • Funds reported $14.2M of Entera Bio stock for Q1 2022, down 11% quarter-over-quarter.
  • 4 funds opened new Entera Bio positions in Q1 2022 and 4 closed out, a net change of 0 holders.
  • The largest Entera Bio buyer in Q1 2022 was Millennium Management, an estimated $111K added.
  • The largest Entera Bio seller in Q1 2022 was ARK Investment Management, an estimated $1.65M sold.

Based on aggregated 13F filings for Q1 2022.